ECM
EW icon

Eisler Capital Management’s Edwards Lifesciences EW Stock Holding History

Eisler Capital Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$1.56M Sell
20,000
-50,000
-71% -$3.91M 0.01% 525
2025
Q2 		$5.48M Hold
70,000
– – 0.03% 375
2025
Q1 		$5.07M Hold
70,000
– – 0.04% 458
2024
Q4 		$5.08M Buy
+70,000
New +$4.9M 0.02% 434

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return

Eisler Capital Management's EW Position: Q3 2025 in Review

Eisler Capital Management increased its Edwards Lifesciences (EW) stake by 8.5% in Q3 2025, buying an estimated $28.2K and bringing the position to 4,611 shares worth $359K. The position accounts for ﹤0.01% of the portfolio, ranked #662.

Eisler Capital Management first reported a position in EW in Q4 2024 and has held it in 4 quarters since. The position peaked at $984K in Q4 2024. 1,253 funds tracked by Wall St. Rank hold EW as of Q3 2025.

  • Eisler Capital Management held 4,611 shares of Edwards Lifesciences worth $359K as of Q3 2025.
  • Eisler Capital Management bought 361 Edwards Lifesciences shares in Q3 2025, an estimated $28.2K.
  • Edwards Lifesciences made up ﹤0.01% of Eisler Capital Management's portfolio in Q3 2025, its #662 holding.
  • Eisler Capital Management first reported a position in Edwards Lifesciences in Q4 2024 and has held it in 4 quarters since.
  • Eisler Capital Management's Edwards Lifesciences position peaked at $984K in Q4 2024.
  • 1,253 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2025.

Based on Eisler Capital Management's 13F filing for Q3 2025, filed 13 Nov 2025.